|
JOSD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.065200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.417650E-01 |
| Normal-vs-Stage2 |
1.914990E-01 |
| Normal-vs-Stage3 |
2.829000E-01 |
| Normal-vs-Stage4 |
3.074500E-02 |
| Stage1-vs-Stage2 |
9.304400E-01 |
| Stage1-vs-Stage3 |
8.663000E-01 |
| Stage1-vs-Stage4 |
2.731800E-01 |
| Stage2-vs-Stage3 |
8.378200E-01 |
| Stage2-vs-Stage4 |
3.017200E-01 |
| Stage3-vs-Stage4 |
2.644000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.855440E-01 |
| Normal-vs-AfricanAmerican |
3.085800E-01 |
| Normal-vs-Asian |
1.528230E-02 |
| Caucasian-vs-AfricanAmerican |
7.498000E-01 |
| Caucasian-vs-Asian |
1.364170E-01 |
| AfricanAmerican-vs-Asian |
1.013960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.247040E-01 |
| Normal-vs-Female |
6.226400E-01 |
| Male-vs-Female |
1.913580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.486240E-02 |
| Normal-vs-Extreme_Weight |
9.210400E-02 |
| Normal-vs-Obese |
6.980200E-01 |
| Normal-vs-Extreme_Obese |
6.641800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.817000E-01 |
| Normal_Weight-vs-Obese |
3.001600E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.472000E-01 |
| Extreme_Weight-vs-Obese |
1.435980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.918800E-01 |
| Obese-vs-Extreme_Obese |
1.860610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.608400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.841600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.527900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.778340E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.774100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.778380E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.261900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.534410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.572000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.247400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.615800E-01 |
| Normal-VS-Type2 PRCC |
1.448550E-04 |
| Normal-VS-KIRP CIMP |
7.598700E-03 |
| Normal-VS-Unclassified PRCC |
2.055800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.9379000000016E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.779800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.191000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.45969999976181E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.551610E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.396100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.040800E-03 |
| Normal-vs-N1 |
8.736400E-01 |
| Normal-vs-N2 |
8.409600E-01 |
| N0-vs-N1 |
7.352000E-02 |
| N0-vs-N2 |
1.286610E-01 |
| N1-vs-N2 |
8.384400E-01 |
|
|
